| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |